Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events.

Journal of the American Heart Association
Peter WilleitSotirios Tsimikas

Abstract

Background Conventional "low-density lipoprotein cholesterol (LDL-C)" assays measure cholesterol content in both low-density lipoprotein and lipoprotein(a) particles. To clarify the consequences of this methodological limitation for clinical care, our study aimed to compare associations of "LDL-C" and corrected LDL-C with risk of cardiovascular disease and to assess the impact of this correction on the classification of patients into guideline-recommended LDL-C categories. Methods and Results Lipoprotein(a) cholesterol content was estimated as 30% of lipoprotein(a) mass and subtracted from "LDL-C" to obtain corrected LDL-C values (LDL-Ccorr30). Hazard ratios for cardiovascular disease (defined as coronary heart disease, stroke, or coronary revascularization) were quantified by individual-patient-data meta-analysis of 5 statin landmark trials from the Lipoprotein(a) Studies Collaboration (18 043 patients; 5390 events; 4.7 years median follow-up). When comparing top versus bottom quartiles, the multivariable-adjusted hazard ratio for cardiovascular disease was significant for "LDL-C" (1.17; 95% CI, 1.05-1.31; P=0.005) but not for LDL-Ccorr30 (1.07; 95% CI, 0.93-1.22; P=0.362). In a routine laboratory database involving 531 144 pa...Continue Reading

References

Jan 1, 1974·Lipids·J J Albers, W R Hazzard
Nov 15, 1994·Biochemistry·G M FlessR Mora
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Apr 13, 2001·JAMA : the Journal of the American Medical Association·G G SchwartzUNKNOWN Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Jul 22, 2005·The New England Journal of Medicine·Christoph WannerUNKNOWN German Diabetes and Dialysis Study Investigators
May 5, 2010·International Journal of Epidemiology·Simon ThompsonUNKNOWN Emerging Risk Factors Collaboration
Oct 23, 2010·European Heart Journal·Børge G NordestgaardUNKNOWN European Atherosclerosis Society Consensus Panel
Apr 12, 2011·Journal of Lipid Research·Stefania Lamon-FavaErnst J Schaefer
Jun 16, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kiyoko KinparaToshio Murase
Mar 19, 2014·Journal of the American College of Cardiology·Rodrigo AlonsoUNKNOWN SAFEHEART Investigators
Apr 15, 2016·Journal of Lipid Research·Konrad SchmidtGerd Utermann
Oct 28, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Steve VarvelSotirios Tsimikas
Nov 3, 2016·Journal of Lipid Research·Børge G Nordestgaard, Anne Langsted
Dec 23, 2016·Journal of the American College of Cardiology·Connor A EmdinUNKNOWN CARDIoGRAM Exome Consortium
Jan 8, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Patrick M MoriartySotirios Tsimikas
Jan 14, 2017·Journal of the American College of Cardiology·Young Sup ByunUNKNOWN SPARCL Trial Investigators
Jan 13, 2018·Journal of the American College of Cardiology·Sotirios TsimikasLijuan Liu
May 16, 2018·Clinical Chemistry·Michel R LangloisUNKNOWN European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Join
Nov 8, 2018·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN ODYSSEY OUTCOMES Committees and Investigators
Dec 28, 2018·Circulation·Michelle L O'DonoghueMarc S Sabatine
Jan 5, 2019·European Heart Journal·Anne LangstedBørge G Nordestgaard
Sep 11, 2019·European Heart Journal·François MachUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.